CTL26
CTL26 is a potent and orally active α-glucosidase inhibitor with an IC50 value of 2.81 µM. CTL26 shows anti-diabetic efficacy[1].
Product Specifications
UNSPSC
12352005
Target
Glycosidase
Type
Reference compound
Related Pathways
Metabolic Enzyme/Protease
Field of Research
Metabolic Disease
Assay Protocol
https://www.medchemexpress.com/ctl26.html
Smiles
O=C(NNC(NC1=CC([N+]([O-])=O)=CC=C1)=S)C2=CC3=C(C(C4=CC=CC=C4)=N2)NC5=CC=CC=C53
Molecular Formula
C25H18N6O3S
Molecular Weight
482.51
References & Citations
[1]Liang B, et al. Novel thiosemicarbazide-based β-carboline derivatives as α-glucosidase inhibitors: Synthesis and biological evaluation. Eur J Med Chem. 2024 Jun 12;275:116595.
Shipping Conditions
Room temperature
Scientific Category
Reference compound1
Clinical Information
No Development Reported
Frequently Asked Questions
More Discoveries
Explore Other Products
Browse additional items from our catalog
MBS2126038-01 0.1 mL
Cy3-Linked Polyclonal Antibody to Milk Fat Globule EGF Factor 8 (MFGE8)
Sign In for Pricing
View Details